Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $352,097 - $407,368
-9,748 Reduced 5.81%
157,964 $5.79 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $237,324 - $308,962
-6,025 Reduced 3.47%
167,712 $6.84 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $191,883 - $250,482
4,596 Added 2.72%
173,737 $8.9 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $646,685 - $789,440
-14,778 Reduced 8.04%
169,141 $7.4 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $7.61 Million - $9.03 Million
-163,619 Reduced 47.08%
183,919 $9.64 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $5.33 Million - $6.61 Million
-116,609 Reduced 25.12%
347,538 $18 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $5.3 Million - $7.86 Million
-128,290 Reduced 21.65%
464,147 $27.4 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $703,713 - $903,980
17,929 Added 3.12%
592,437 $25.5 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $6.55 Million - $7.42 Million
-182,489 Reduced 24.11%
574,508 $22.5 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $21.9 Million - $24.7 Million
-654,513 Reduced 46.37%
756,997 $27.4 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $7.36 Million - $9.35 Million
219,774 Added 18.44%
1,411,510 $52 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $3.04 Million - $3.57 Million
-95,748 Reduced 7.44%
1,191,736 $43.7 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $9.85 Million - $11.9 Million
-326,997 Reduced 20.25%
1,287,484 $42.1 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $43.6 Million - $62.4 Million
1,614,481 New
1,614,481 $50 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sirios Capital Management L P Portfolio

Follow Sirios Capital Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sirios Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Sirios Capital Management L P with notifications on news.